We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-14.3%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$85.3B
AUM Growth
-$21.5B
Cap. Flow
-$8.24B
Cap. Flow %
-9.67%
Top 10 Hldgs %
8.52%
Holding
6,080
New
596
Increased
1,780
Reduced
1,836
Closed
791

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Financials 10.31%
3 Healthcare 7.77%
4 Consumer Discretionary 7.11%
5 Industrials 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPOD.WS
4776
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$29K ﹤0.01%
62,500
JOBY.WS icon
4777
Joby Aviation Warrants
JOBY.WS
$28K ﹤0.01%
26,246
YRD
4778
Yiren Digital
YRD
$103M
$28K ﹤0.01%
15,444
CYCUW
4779
Cycurion Inc Warrant
CYCUW
$198K
$28K ﹤0.01%
+250,000
New +$34K
SOAR.WS
4780
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$28K ﹤0.01%
275,000
CMCAW
4781
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$28K ﹤0.01%
275,005
LIVBW
4782
DELISTED
LIV Capital Acquisition Corp. II Warrants
LIVBW
$28K ﹤0.01%
281,250
+187,500
+200% +$27.8K
CALA
4783
DELISTED
Calithera Biosciences, Inc
CALA
$28K ﹤0.01%
11,249
-728
-6% -$3.38K
DNA icon
4784
Ginkgo Bioworks
DNA
$481M
$27K ﹤0.01%
285
-55,009
-99% -$6.71M
ESLAW icon
4785
Estrella Immunopharma Warrant
ESLAW
$27K ﹤0.01%
87,500
EUDAW icon
4786
EUDA Health Holdings Warrant
EUDAW
$219K
$27K ﹤0.01%
133,334
MRKR icon
4787
Marker Therapeutics
MRKR
$20.3M
$27K ﹤0.01%
8,212
-1,609
-16% -$5.35K
MCAAW
4788
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$27K ﹤0.01%
274,999
NUBIW
4789
DELISTED
Nubia Brand International Corp. Warrant
NUBIW
$27K ﹤0.01%
+247,500
New +$33.9K
FRXB.WS
4790
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$27K ﹤0.01%
89,549
RACYW
4791
DELISTED
Relativity Acquisition Corp. Warrant
RACYW
$27K ﹤0.01%
+300,000
New +$44K
RDZNW icon
4792
Roadzen Inc Warrants
RDZNW
$6.91M
$26K ﹤0.01%
175,000
PNST.WS
4793
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$26K ﹤0.01%
199,999
+158,333
+380% +$27K
SUAC.WS
4794
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$26K ﹤0.01%
199,999
ADALW
4795
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$26K ﹤0.01%
212,500
IQMDW
4796
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$26K ﹤0.01%
199,999
LHDX
4797
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$26K ﹤0.01%
13,866
-5,782
-29% -$14.1K
ZVSAW
4798
DELISTED
ZyVersa Therapeutics, Inc. Warrants
ZVSAW
$26K ﹤0.01%
262,499
+175,000
+200% +$30.4K
TSPQ.WS
4799
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$26K ﹤0.01%
119,337
ADRT.WS
4800
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$26K ﹤0.01%
262,499
+175,000
+200% +$18K

Similar funds

D.E. Shaw & Co's Q2 2022 Portfolio in Review

As of Q2 2022, D.E. Shaw & Co held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

D.E. Shaw & Co withdrew a net $8.24B in Q2 2022, closing 791 positions and reducing 1,836 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in iShares MSCI Emerging Markets ETF worth $171M.

  • D.E. Shaw & Co's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
  • D.E. Shaw & Co added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
  • D.E. Shaw & Co's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
  • D.E. Shaw & Co fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
  • D.E. Shaw & Co's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
  • D.E. Shaw & Co opened 596 new positions and closed 791 in Q2 2022.
  • D.E. Shaw & Co's portfolio value fell 20% quarter-over-quarter to $85.3B.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.